• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[感染人类免疫缺陷病毒患者的锌与淋巴细胞亚群]

[Zinc and lymphocyte subsets in patients with HIV infection].

作者信息

Libanore M, Bicocchi R, Raise E, Sighinolfi L, Bedetti A, Montanari P, Fagioli F, Benini A, Schiattone M L, Ghinelli F

机构信息

Regione Emilia-Romagna U.S.L. n. 31-Arcispedale S. Anna-Ferrara.

出版信息

Minerva Med. 1987 Dec 31;78(24):1805-12.

PMID:2963239
Abstract

Serum zinc levels were assayed in patients with AIDS and related syndromes, using spectrophotometry and atomic absorption. Statistical data have shown that serum zinc levels, in addition to being significantly lower (p less than 0.001) among different groups and controls, decrease progressively with the worsening of the clinical and immunological picture from LAS to AIDS. Serum zinc levels in patients with AIDS and ARC have, moreover, been demonstrated to be related (r = 0.8240; p less than 0.001) to the lymphocyte subset CD4 helper-induced. These results suggest that serum zinc determination and possibly zinc therapy might be reasonably considered in the management of patients with symptoms of HIV infection.

摘要

采用分光光度法和原子吸收法对艾滋病患者及相关综合征患者的血清锌水平进行了测定。统计数据表明,血清锌水平不仅在不同组和对照组中显著降低(p<0.001),而且随着临床和免疫状况从淋巴结病相关综合征(LAS)到艾滋病的恶化而逐渐下降。此外,艾滋病患者和艾滋病相关综合征(ARC)患者的血清锌水平已被证明与淋巴细胞亚群CD4辅助诱导相关(r = 0.8240;p<0.001)。这些结果表明,在管理有HIV感染症状的患者时,合理考虑测定血清锌水平并可能进行锌治疗。

相似文献

1
[Zinc and lymphocyte subsets in patients with HIV infection].[感染人类免疫缺陷病毒患者的锌与淋巴细胞亚群]
Minerva Med. 1987 Dec 31;78(24):1805-12.
2
Neopterin as discriminating and prognostic parameter in healthy homosexuals, ARC and AIDS patients.
Wien Klin Wochenschr. 1987 Aug 7;99(15):531-5.
3
[Clinical observation of the changes of serum helper T-lymphocytes (TH) cytokines in patients with HIV-infection and opportunistic infection].[人类免疫缺陷病毒感染及机会性感染患者血清辅助性T淋巴细胞(TH)细胞因子变化的临床观察]
Zhonghua Yu Fang Yi Xue Za Zhi. 2007 Jan;41(1):42-5.
4
[Determination, by the immunogold method, of T lymphocyte sub-populations during HIV infections (LAV/HTLV III)].[应用免疫金法测定HIV感染(LAV/HTLV III)期间的T淋巴细胞亚群]
Ann Biol Clin (Paris). 1987;45(3):304-7.
5
Comparative analysis of CD4-4B4 and CD4-2H4 lymphocyte subpopulations in HIV negative homosexual, HIV seropositive and healthy subjects.HIV阴性同性恋者、HIV血清阳性者及健康受试者中CD4-4B4和CD4-2H4淋巴细胞亚群的比较分析。
Clin Exp Immunol. 1988 Jan;71(1):8-12.
6
Effect of zidovudine on serum human immunodeficiency virus core antigen levels. Results from a placebo-controlled trial.齐多夫定对血清人类免疫缺陷病毒核心抗原水平的影响。一项安慰剂对照试验的结果。
Arch Intern Med. 1988 Oct;148(10):2151-3.
7
Quantitative changes in T helper inducer (CD4+ CD45RA-), T suppressor inducer (CD4+ CD45RA+), T suppressor (CD8+ CD11b+), and T cytotoxic (CD8+ CD11b-) subsets in human immunodeficiency virus infection.人类免疫缺陷病毒感染中辅助性T诱导细胞(CD4+ CD45RA-)、抑制性T诱导细胞(CD4+ CD45RA+)、抑制性T细胞(CD8+ CD11b+)和细胞毒性T细胞(CD8+ CD11b-)亚群的定量变化
J Clin Lab Anal. 1991;5(2):96-100. doi: 10.1002/jcla.1860050205.
8
A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).获得性免疫缺陷综合征(艾滋病)发展过程中主要组织相容性复合体自身限制性T细胞免疫反应选择性丧失的模型。
J Immunol. 1986 Oct 15;137(8):2514-21.
9
Isoferritins in HIV infection: relation to clinical stage, CD8 lymphocyte binding and the pathogenesis of AIDS.HIV感染中的异铁蛋白:与临床分期、CD8淋巴细胞结合及艾滋病发病机制的关系。
AIDS. 1989 Jan;3(1):11-6.
10
Immunologic abnormalities related to antigenaemia during HIV-1 infection.与HIV-1感染期间抗原血症相关的免疫异常。
Clin Exp Immunol. 1988 Dec;74(3):317-20.

引用本文的文献

1
Effect of Human Immunodeficiency Virus on Trace Elements in the Brain.人类免疫缺陷病毒对大脑中微量元素的影响。
Biol Trace Elem Res. 2021 Jan;199(1):41-52. doi: 10.1007/s12011-020-02129-4. Epub 2020 Apr 1.